TMR's report on the global knee cartilage repair market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global knee cartilage repair market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global knee cartilage repair market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the knee cartilage repair market.
Market Snapshot
Market Value in 2023
US$ 1.7 Bn
Market Value in 2031
US$ 2.9 Bn
CAGR
6%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global knee cartilage repair market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global knee cartilage repair market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global knee cartilage repair market.
The report delves into the competitive landscape of the global knee cartilage repair market. Key players operating in the global knee cartilage repair market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global knee cartilage repair market profiled in this report.
Key Questions Answered in Global knee cartilage repair Market Report:
What is the sales/revenue generated by knee cartilage repair across all regions during the forecast period?
What are the opportunities in the global knee cartilage repair market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Knee Cartilage Repair Market - Research Objectives and Research Approach
The comprehensive report on the global knee cartilage repair market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global knee cartilage repair market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global knee cartilage repair market.
Table of Contents
1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Knee Cartilage Repair Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Knee Cartilage Repair Market Analysis and Forecasts, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. List of Biologicals Used in Knee Cartilage Repair
5.3. COVID-19 Pandemic Impact on Industry
6. Knee Cartilage Repair Market Analysis and Forecast, by Application
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Application, 2023-2031
6.3.1. Arthroscopic Chondroplasty
6.3.2. Autologous Chondrocyte Implantation
6.3.3. Osteochondral Graft Transplantation
6.3.4. Cell-based Cartilage Resurfacing
6.3.5. Implant Transplant
6.3.6. Microfracture
6.3.7. Others
6.4. Market Attractiveness, by Application
7. Global Knee Cartilage Repair Market Analysis and Forecast, by End-user
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2023-2031
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Orthopedic Clinics
7.3.4. Others
7.4. Market Attractiveness, by End-user
8. Global Knee Cartilage Repair Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2023-2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Region
9. North America Knee Cartilage Repair Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Application, 2023-2031
9.2.1. Arthroscopic Chondroplasty
9.2.2. Autologous Chondrocyte Implantation
9.2.3. Osteochondral Graft Transplantation
9.2.4. Cell-based Cartilage Resurfacing
9.2.5. Implant Transplant
9.2.6. Microfracture
9.2.7. Others
9.3. Market Value Forecast, by End-user, 2023-2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Orthopedic Clinics
9.3.4. Others
9.4. Market Value Forecast, by Country, 2023-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By End-user
9.5.3. By Country
10. Europe Knee Cartilage Repair Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Application, 2023-2031
10.2.1. Arthroscopic Chondroplasty
10.2.2. Autologous Chondrocyte Implantation
10.2.3. Osteochondral Graft Transplantation
10.2.4. Cell-based Cartilage Resurfacing
10.2.5. Implant Transplant
10.2.6. Microfracture
10.2.7. Others
10.3. Market Value Forecast, by End-user, 2023-2031
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Orthopedic Clinics
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2023-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Knee Cartilage Repair Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Application, 2023-2031
11.2.1. Arthroscopic Chondroplasty
11.2.2. Autologous Chondrocyte Implantation
11.2.3. Osteochondral Graft Transplantation
11.2.4. Cell-based Cartilage Resurfacing
11.2.5. Implant Transplant
11.2.6. Microfracture
11.2.7. Others
11.3. Market Value Forecast, by End-user, 2023-2031
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centers
11.3.3. Orthopedic Clinics
11.3.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2023-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Knee Cartilage Repair Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Application, 2023-2031
12.2.1. Arthroscopic Chondroplasty
12.2.2. Autologous Chondrocyte Implantation
12.2.3. Osteochondral Graft Transplantation
12.2.4. Cell-based Cartilage Resurfacing
12.2.5. Implant Transplant
12.2.6. Microfracture
12.2.7. Others
12.3. Market Value Forecast, by End-user, 2023-2031
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Orthopedic Clinics
12.3.4. Others
12.4. Market Value Forecast, by Country/Sub-region, 2023-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Knee Cartilage Repair Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Application, 2023-2031
13.2.1. Arthroscopic Chondroplasty
13.2.2. Autologous Chondrocyte Implantation
13.2.3. Osteochondral Graft Transplantation
13.2.4. Cell-based Cartilage Resurfacing
13.2.5. Implant Transplant
13.2.6. Microfracture
13.2.7. Others
13.3. Market Value Forecast, by End-user, 2023-2031
13.3.1. Hospitals
13.3.2. Ambulatory Surgical Centers
13.3.3. Orthopedic Clinics
13.3.4. Others
13.4. Market Value Forecast, by Country/Sub-region, 2023-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Application
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Zimmer Biomet Holdings, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Smith & Nephew PLC
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Histogenics Corporation
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Medipost Co. Ltd.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. TiGenix NV
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. DePuy Synthes
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Vericel Corporation
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Stryker Corporation
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. B. Braun Melsungen AG
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. ISTO Technologies Inc.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Osiris Therapeutics, Inc.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)